Following the landmark SPRINT trial, there is a growing body of evidence for reducing systolic blood pressure targets, resulting in the development of new US guidelines. However, this has led to many questions about the impact of such fundamental changes in blood pressure management, and whether they should be implemented in other constituencies. Two studies… Continue reading How Low Is Too Low? Experts Debate Blood Pressure Targets in the Post-SPRINT Era